Literature DB >> 21913320

N-acetyl cysteine protects osteoblastic function from oxidative stress.

T Ueno1, M Yamada, Y Igarashi, T Ogawa.   

Abstract

We tested the protective potential of an antioxidant amino acid derivative, N-acetyl cysteine (NAC), in controlling oxidative stress against osteoblasts. Osteoblastic cells extracted from rat bone marrow were cultured. Oxidative stress was induced by adding 100 μM H₂O₂ into the culture media. Then, some H₂O₂-treated cultures were cotreated with 2.5 or 5 mM NAC. Addition of H₂O₂ decreased the number of cells to 50% of untreated cultures at days 2. Addition of 5 mM NAC into H₂O₂ cultures resulted in a dose-dependent increase in the number of cells, with the cell number being 50% greater than that in the 100 μM H₂O₂ culture. The gene expression levels of type I collagen, osteopontin, and osteocalcin were downregulated threefold by H₂O₂ on day 7. The H₂O₂-suppressed gene expression was fully recovered by NAC cotreatment. The mineralizing capability, assessed by Von Kossa staining on day 15, were approximately 1.8 times greater in the NAC + H₂O₂ cotreated group than in the culture with H₂O₂ alone. These NAC-mediated restorations were associated with an NAC dose-dependent increase of intracellular glutathione and a NAC dose-dependent decrease of intracellular reactive oxygen species. In conclusion, oxidative stress induced by H₂O₂ substantially impairs the proliferation, differentiation, and mineralization of osteoblasts. More importantly, the addition of NAC into the culture was found to restore these damages to a near normal level due to the improved redox balance, warranting further in vivo studies to test its therapeutic potential as a local antioxidative stress drug.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913320     DOI: 10.1002/jbm.a.33211

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  11 in total

Review 1.  Oxidative stress in bone remodeling: role of antioxidants.

Authors:  Vladana Domazetovic; Gemma Marcucci; Teresa Iantomasi; Maria Luisa Brandi; Maria Teresa Vincenzini
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

2.  Irradiation inhibits the maturation and mineralization of osteoblasts via the activation of Nrf2/HO-1 pathway.

Authors:  Sung-Ho Kook; Kyoung-A Kim; Hyeok Ji; Daewoo Lee; Jeong-Chae Lee
Journal:  Mol Cell Biochem       Date:  2015-09-07       Impact factor: 3.396

3.  Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.

Authors:  Jian-Qing Zhang; Jia-Qiang Zhang; Hua Liu; Zhi-Huan Zhao; Li-Zhou Fang; Ling Liu; Wei-Ping Fu; Jing-Kui Shu; Jia-Gang Feng; Lu-Ming Dai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-13

4.  N-acetylcysteine-functionalized coating avoids bacterial adhesion and biofilm formation.

Authors:  Fabíola Costa; Daniela M Sousa; Paula Parreira; Meriem Lamghari; Paula Gomes; M Cristina L Martins
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

5.  Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.

Authors:  Yuuki Yamaguchi; Hiroyuki Kanzaki; Yuta Katsumata; Kanako Itohiya; Sari Fukaya; Yutaka Miyamoto; Tsuyoshi Narimiya; Satoshi Wada; Yoshiki Nakamura
Journal:  J Cell Mol Med       Date:  2017-10-24       Impact factor: 5.310

6.  Selenium- and Tellurium-Based Antioxidants for Modulating Inflammation and Effects on Osteoblastic Activity.

Authors:  Xi Lu; Gemma Mestres; Vijay Pal Singh; Pedram Effati; Jia-Fei Poon; Lars Engman; Marjam Karlsson Ott
Journal:  Antioxidants (Basel)       Date:  2017-02-14

7.  N-acetyl cysteine inhibits H2O2-mediated reduction in the mineralization of MC3T3-E1 cells by down-regulating Nrf2/HO-1 pathway.

Authors:  Daewoo Lee; Sung-Ho Kook; Hyeok Ji; Seung-Ah Lee; Ki-Choon Choi; Kyung-Yeol Lee; Jeong-Chae Lee
Journal:  BMB Rep       Date:  2015-11       Impact factor: 4.778

Review 8.  Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options.

Authors:  Rouhollah Fathi; Mojtaba Rezazadeh Valojerdi; Bita Ebrahimi; Farideh Eivazkhani; Mahzad Akbarpour; Leila Sadat Tahaei; Naeimeh Sadat Abtahi
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

9.  Risk of Osteoporotic Fracture in Patients with Breast Cancer: Meta-Analysis.

Authors:  Seeyoun Lee; Jun-Il Yoo; Young-Kyun Lee; Jung-Wee Park; Seokhyung Won; Jiung Yeom; Jin Woo Im; Seok Min Lim; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  J Bone Metab       Date:  2020-02-29

10.  High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease (GOLD I-II): study protocol for a multicenter, double-blinded, parallel-group, randomized controlled trial in China.

Authors:  Heshen Tian; Yumin Zhou; Longhui Tang; Fan Wu; Zhishan Deng; Bijia Lin; Peiyu Huang; Shaodan Wei; Dongxing Zhao; Jingping Zheng; Nanshan Zhong; Pixin Ran
Journal:  Trials       Date:  2020-09-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.